Evogene Ltd. (NASDAQ:EVGN) Q4 2024 Earnings Call Transcript

Evogene Ltd. (NASDAQ:EVGN) Q4 2024 Earnings Call Transcript March 6, 2025

Evogene Ltd. beats earnings expectations. Reported EPS is $0.06, expectations were $-0.72.

Operator: Welcome to Evogene’s Fourth Quarter Results Conference Call. All participants are present in listen-only mode. Following management’s formal presentation, we will open the question-and-answer session. As a reminder, this conference is being recorded March 6, 2025. Before we begin, I would like to caution that certain...